Negative Symptoms With Primary Psychotic Disorder Clinical Trial
Official title:
Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
Clinical trial to assess the efficacy of Vortioxetine compared with treatment as usual in early schizophrenia.
Clinical trial to assess the efficacy of Vortioxetine, compared with treatment as usual in early schizophrenia. Propose: To investigate the effect of Vortioxetine in cognitive functioning and negative symptoms severity in early schizophrenia. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04024371 -
Validating Reward-related Biomarkers (RTOC)
|
||
| Recruiting |
NCT04789915 -
Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis
|
Phase 1 | |
| Recruiting |
NCT05252039 -
Goals in Focus: CBT for Motivational Negative Symptoms of Psychosis
|
N/A | |
| Recruiting |
NCT04318977 -
rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia
|
N/A |